B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	coherence
I-Diagnostic_tool	18	28	tomography
O	29	36	grading
O	37	52	reproducibility
O	53	59	during
O	60	63	the
O	64	74	Comparison
O	75	77	of
B-Disease	78	81	Age
I-Disease	81	82	-
I-Disease	82	89	related
I-Disease	90	97	Macular
I-Disease	98	110	Degeneration
O	111	121	Treatments
O	122	128	Trials
O	128	129	.

O	131	133	To
O	134	140	report
O	141	148	reading
O	149	155	center
O	156	171	reproducibility
O	172	178	during
O	179	186	grading
O	187	189	of
B-Diagnostic_tool	190	197	Stratus
I-Diagnostic_tool	198	205	optical
I-Diagnostic_tool	206	215	coherence
I-Diagnostic_tool	216	226	tomography
O	227	228	(
B-Diagnostic_tool	228	231	OCT
O	231	232	)
O	233	234	(
O	234	238	Carl
O	239	244	Zeiss
O	245	252	Meditec
O	252	253	,
O	254	260	Dublin
O	260	261	,
O	262	264	CA
O	264	265	)
O	266	272	images
O	273	281	obtained
O	282	288	during
O	289	292	the
O	293	303	Comparison
O	304	306	of
B-Disease	307	310	Age
I-Disease	310	311	-
I-Disease	311	318	Related
I-Disease	319	326	Macular
I-Disease	327	339	Degeneration
O	340	350	Treatments
O	351	357	Trials
O	358	359	(
O	359	363	CATT
O	363	364	)
O	364	365	.

O	366	377	Prospective
O	377	378	,
O	379	387	clinical
O	388	393	trial
O	393	394	.

O	395	406	Independent
O	407	414	reading
O	415	420	teams
O	421	432	reevaluated
O	433	436	270
B-Diagnostic_tool	437	440	OCT
O	441	446	scans
O	447	455	randomly
O	456	463	sampled
O	464	468	from
O	469	472	the
O	473	478	first
O	479	480	2
O	481	486	years
O	487	489	of
O	490	494	CATT
O	495	505	enrollment
O	505	506	.

O	507	509	To
O	510	516	assess
O	517	525	temporal
O	526	531	drift
O	531	532	,
O	533	534	a
O	535	541	cohort
O	542	544	of
O	545	547	23
O	548	553	scans
O	554	563	submitted
O	564	570	during
O	571	574	the
O	575	582	initial
O	583	590	portion
O	591	593	of
O	594	597	the
O	598	602	CATT
O	603	608	study
O	609	612	was
O	613	627	longitudinally
O	628	636	followed
O	637	641	with
O	642	648	serial
O	649	664	reproducibility
O	665	673	analysis
O	673	674	.

O	675	678	The
O	679	683	CATT
O	684	691	readers
O	692	701	performed
O	702	714	standardized
O	715	722	grading
O	723	725	of
B-Diagnostic_tool	726	729	OCT
O	730	736	images
O	736	737	.

O	738	739	A
O	740	746	reader
O	747	751	team
O	751	752	,
O	753	761	composed
O	762	764	of
O	765	766	2
O	767	778	independent
O	779	786	readers
O	787	790	and
O	791	792	a
O	793	799	senior
O	800	806	reader
O	806	807	,
O	808	817	evaluated
O	818	822	each
O	823	827	scan
O	827	828	.

O	829	836	Grading
O	837	845	included
O	846	849	the
O	850	854	CATT
B-Diagnostic_tool	855	858	OCT
O	859	862	end
O	863	869	points
O	870	872	of
B-Characteristic	873	878	total
I-Characteristic	879	888	thickness
I-Characteristic	889	891	at
I-Characteristic	892	895	the
I-Characteristic	896	902	foveal
I-Characteristic	903	909	center
I-Characteristic	910	915	point
O	916	919	and
B-Symptom	920	932	intraretinal
I-Symptom	933	938	fluid
O	939	940	(
B-Symptom	940	943	IRF
O	943	944	)
O	944	945	,
B-Symptom	946	956	subretinal
I-Symptom	957	962	fluid
O	963	964	(
B-Symptom	964	967	SRF
O	967	968	)
O	968	969	,
O	970	973	and
B-Symptom	974	984	subretinal
I-Symptom	985	992	pigment
I-Symptom	993	1003	epithelium
I-Symptom	1004	1005	(
I-Symptom	1005	1008	RPE
I-Symptom	1008	1009	)
I-Symptom	1010	1015	fluid
O	1015	1016	.

O	1017	1028	Independent
O	1029	1036	reading
O	1037	1042	teams
O	1043	1049	masked
O	1050	1052	to
O	1053	1056	the
O	1057	1064	results
O	1065	1067	of
O	1068	1075	initial
O	1076	1083	grading
O	1084	1095	reevaluated
O	1096	1101	scans
O	1102	1104	to
O	1105	1114	determine
O	1115	1118	the
O	1119	1134	reproducibility
O	1135	1137	of
O	1138	1149	qualitative
O	1150	1157	grading
O	1158	1161	and
O	1162	1174	measurements
O	1174	1175	.

O	1176	1187	Categorical
O	1188	1195	grading
O	1196	1205	agreement
O	1206	1209	was
O	1210	1218	reported
O	1219	1224	using
O	1225	1232	percent
O	1233	1242	agreement
O	1243	1246	and
O	1247	1252	kappa
O	1253	1262	statistic
O	1262	1263	,
O	1264	1267	and
O	1268	1279	measurement
O	1280	1289	agreement
O	1290	1293	was
O	1294	1302	reported
O	1303	1308	using
O	1309	1319	intraclass
O	1320	1332	correlations
O	1333	1336	and
O	1337	1343	paired
O	1344	1355	differences
O	1355	1356	.

O	1357	1364	Reading
O	1365	1371	center
O	1372	1377	teams
O	1378	1390	reproducibly
O	1391	1397	graded
B-Symptom	1398	1401	IRF
O	1402	1403	(
O	1403	1410	percent
O	1411	1420	agreement
O	1421	1422	=
O	1423	1425	73
O	1425	1426	%
O	1426	1427	,
O	1428	1433	kappa
O	1434	1435	=
O	1436	1437	0
O	1437	1438	.
O	1438	1440	48
O	1440	1441	;
O	1442	1444	95
O	1444	1445	%
O	1446	1456	confidence
O	1457	1465	interval
O	1466	1467	[
O	1467	1469	CI
O	1469	1470	]
O	1470	1471	,
O	1472	1473	0
O	1473	1474	.
O	1474	1476	38
O	1476	1477	-
O	1477	1478	0
O	1478	1479	.
O	1479	1481	58
O	1481	1482	)
O	1482	1483	,
B-Symptom	1484	1487	SRF
O	1488	1489	(
O	1489	1496	percent
O	1497	1506	agreement
O	1507	1508	=
O	1509	1511	90
O	1511	1512	%
O	1512	1513	;
O	1514	1519	kappa
O	1520	1521	=
O	1522	1523	0
O	1523	1524	.
O	1524	1526	80
O	1526	1527	;
O	1528	1530	95
O	1530	1531	%
O	1532	1534	CI
O	1534	1535	,
O	1536	1537	0
O	1537	1538	.
O	1538	1540	73
O	1540	1541	-
O	1541	1542	0
O	1542	1543	.
O	1543	1545	87
O	1545	1546	)
O	1546	1547	,
O	1548	1551	and
B-Symptom	1552	1555	sub
I-Symptom	1555	1556	-
I-Symptom	1556	1559	RPE
I-Symptom	1560	1565	fluid
O	1566	1567	(
O	1567	1574	percent
O	1575	1584	agreement
O	1585	1587	88
O	1587	1588	%
O	1588	1589	;
O	1590	1595	kappa
O	1596	1597	=
O	1598	1599	0
O	1599	1600	.
O	1600	1602	75
O	1602	1603	;
O	1604	1606	95
O	1606	1607	%
O	1608	1610	CI
O	1610	1611	,
O	1612	1613	0
O	1613	1614	.
O	1614	1616	67
O	1616	1617	-
O	1617	1618	0
O	1618	1619	.
O	1619	1621	83
O	1621	1622	)
O	1622	1623	.

O	1624	1627	For
O	1628	1639	independent
O	1640	1647	reading
O	1648	1654	center
O	1655	1659	team
O	1660	1672	measurements
O	1673	1675	of
B-Characteristic	1676	1681	total
I-Characteristic	1682	1691	thickness
I-Characteristic	1692	1694	at
I-Characteristic	1695	1698	the
I-Characteristic	1699	1705	foveal
I-Characteristic	1706	1712	center
I-Characteristic	1713	1718	point
O	1718	1719	,
O	1720	1723	the
O	1724	1734	intraclass
O	1735	1746	correlation
O	1747	1750	was
O	1751	1752	0
O	1752	1753	.
O	1753	1755	99
O	1756	1757	(
O	1757	1759	95
O	1759	1760	%
O	1761	1763	CI
O	1763	1764	,
O	1765	1766	0
O	1766	1767	.
O	1767	1769	99
O	1769	1770	-
O	1770	1771	0
O	1771	1772	.
O	1772	1774	99
O	1774	1775	)
O	1775	1776	,
O	1777	1780	and
O	1781	1784	the
O	1785	1789	mean
O	1790	1796	paired
O	1797	1807	difference
O	1808	1815	between
O	1816	1823	reading
O	1824	1830	center
O	1831	1836	teams
O	1837	1840	was
O	1841	1842	4
O	1843	1844	μ
O	1844	1845	m
O	1846	1847	(
O	1847	1849	95
O	1849	1850	%
O	1851	1857	limits
O	1858	1860	of
O	1861	1870	agreement
O	1870	1871	,
O	1872	1873	-
O	1873	1875	55
O	1876	1878	to
O	1879	1881	47
O	1882	1883	μ
O	1883	1884	m
O	1884	1885	)
O	1885	1886	.

O	1887	1892	There
O	1893	1896	was
O	1897	1899	no
O	1900	1911	qualitative
O	1912	1914	or
O	1915	1927	quantitative
O	1928	1935	grading
O	1936	1941	drift
O	1941	1942	.

O	1943	1946	The
O	1947	1959	standardized
O	1960	1969	protocols
O	1970	1974	used
O	1975	1977	to
O	1978	1986	evaluate
B-Diagnostic_tool	1987	1990	OCT
O	1991	1996	scans
O	1997	2001	from
O	2002	2005	the
O	2006	2010	CATT
O	2011	2016	study
O	2017	2021	were
O	2022	2034	reproducible
O	2034	2035	.

O	2036	2039	The
O	2040	2047	methods
O	2048	2052	used
O	2053	2056	are
O	2057	2065	suitable
O	2066	2068	to
O	2069	2076	monitor
B-Diagnostic_tool	2077	2080	OCT
O	2081	2088	imaging
O	2089	2093	data
O	2094	2098	from
O	2099	2100	a
O	2101	2106	large
O	2106	2107	,
B-Disease	2108	2119	neovascular
I-Disease	2120	2123	age
I-Disease	2123	2124	-
I-Disease	2124	2131	related
I-Disease	2132	2139	macular
I-Disease	2140	2152	degeneration
O	2152	2153	,
O	2154	2168	interventional
O	2168	2169	,
O	2170	2181	multicenter
O	2182	2187	study
O	2187	2188	.

O	2189	2192	The
O	2193	2199	author
O	2199	2200	(
O	2200	2201	s
O	2201	2202	)
O	2203	2207	have
O	2208	2210	no
O	2211	2222	proprietary
O	2223	2225	or
O	2226	2236	commercial
O	2237	2245	interest
O	2246	2248	in
O	2249	2252	any
O	2253	2262	materials
O	2263	2272	discussed
O	2273	2275	in
O	2276	2280	this
O	2281	2288	article
O	2288	2289	.
